EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models

John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, Victoria Andre, Elric Zhang, Veronica Estrella, Kazim Husain, Joseph Weygand, Doug Marchion, Alex Sebastian Lopez, Dominique Abrahams, Shawnus Chen und 17 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202517228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von John Michael Bryant und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, Defense Advanced Research Projects Agency, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnetoelectric nanoparticles (MENPs), when activated by a magnetic field, are shown to provide a minimally invasive, drug‐free, theranostic approach to pancreatic ductal adenocarcinoma (PDAC) treatment. The magnetoelectric effect allows intravenously administered MENPs to be magnetically guided to PDAC tumors and remotely activated with a 7T‐MRI field to induce targeted, electrode‐free tumor ablation with real‐time imaging feedback. A single MENP treatment achieved a threefold median reduction in tumor volume and complete tumor responses in 33.3 % of mice at 300 and 600 µg doses ( N = 17) and significantly longer mean overall survival as compared to the control cohorts (54.1 vs 28.8 days, χ 2 = 40.14, p = 0.045), without evident toxicity in any imaged organ. In contrast, mice receiving subtherapeutic doses, non‐activated MENPs, or saline controls showed no significant response. MRI T 2 * relaxation time decreases closely correlated with tumor reduction (ρ = −0.73, p < 0.001), supporting MENPs as both a therapeutic and imaging biomarker. Mechanistically, MENPs preferentially target cancer cells via magnetic‐field‐driven electrostatic interactions specific to tumor cell membranes, in agreement with multiphysics numerical simulations. Flow cytometry confirmed that MENP activation primarily induces apoptosis, with minimal necrosis, and time‐course studies showed a progressive apoptotic response over 3‐hour post‐treatment. The findings establish MENPs as a versatile, image‐guided, theranostic platform with translational promise for minimally invasive oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalAnimalsMiceDisease Models, AnimalMagnetic Resonance ImagingCell Line, TumorHumansFemaleTheranostic Nanomedicine

Stichwörter der Autor:innen

magnetoelectric nanoparticlespancreatic cancertheranostics

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
  • Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • College of Engineering, University of Miami, Coral Gables, FL, 33146, USA.
  • Cancer Physiology/Clinical Science Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
  • The Institute of Robotics and Intelligent Systems, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, 8092, Switzerland.
  • Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.

ORCID-Profile: Sakhrat Khizroev

Förderung

  • National Science Foundation
  • Defense Advanced Research Projects Agency
  • NCI NIH HHS
  • Radiological Society of North America (RSNA)
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bryant, J. M., Shotbolt, M., Stimphil, E., Andre, V., Zhang, E., Estrella, V., Husain, K., Weygand, J., Marchion, D., Lopez, A. S., Abrahams, D., Chen, S., Abdel-Mottaleb, M., Conlan, S., Oraiqat, I., Khatri, V., Guevara, J. A., Pilon-Thomas, S., Redler, G., …, & Khizroev, S. (2026). Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models. Advanced Science. https://doi.org/10.1002/advs.202517228

Vancouver

Bryant JM, Shotbolt M, Stimphil E, Andre V, Zhang E, Estrella V, et al. Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models. Advanced Science. 2026. doi:10.1002/advs.202517228

BibTeX
@article{Bryant2026,
  author = {Bryant, John Michael and Shotbolt, Max and Stimphil, Emmanuel and Andre, Victoria and Zhang, Elric and Estrella, Veronica and Husain, Kazim and Weygand, Joseph and Marchion, Doug and Lopez, Alex Sebastian and Abrahams, Dominique and Chen, Shawnus and Abdel-Mottaleb, Mostafa and Conlan, Skye and Oraiqat, Ibrahim and Khatri, Vaseem and Guevara, Jose Alejandro and Pilon-Thomas, Shari and Redler, Gage and Latifi, Kujtim and Raghunand, Natarajan and Yamoah, Kosj and Hoffe, Sarah and Costello, James and Frakes, Jessica M and Liang, Ping and Gatenby, Robert A and Malafa, Mokenge and Khizroev, Sakhrat},
  title = {Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202517228}
}
Kostenlos starten →